High-Intensity Interval Training May Improve Cardiorespiratory Fitness After Stroke
Findings from a new study suggest high-intensity interval training may be more effective in improving individuals’ cardiorespiratory fitness poststroke than moderate-intensity continuous training.
Long COVID Risk Declined Over the Pandemic: Daily Dose
Your daily dose of the clinical news you may have missed.
FDA Approves First Intranasal Epinephrine for Emergency Treatment of Allergic Reactions
neffy (epinephrine nasal spray) is the first alternative to epinephrine administered by autoinjector or syringe and is comparable in efficacy to the gold standard.
US 2023 Mortality Rate Drops 6% as COVID-19 Slides to 10th Leading Cause: New CDC Data
COVID-19 as a cause of death fell from the #4 spot in 2022 to #10 in 2023, which may account for some of the overall decline in the US mortality rate, suggest CDC experts.
ACIP Recommendations for RSV Vaccines in Older Adults: Update August 2024
The Advisory Committee on Immunization Practices' revisions prioritize vulnerable older adults and those at higher risk of severe infection.
Visit to Primary Care Soon After Cancer Surgery Associated with Reduced Mortality Risk in Older Adults
In a new study of older adults who underwent cancer surgery, those who visited their PCP within 90 days had a significantly lower postoperative mortality rate.
Roflumilast Cream 0.15% Approved for Treatment of Atopic Dermatitis in Adults, Children: Daily Dose
Subtle Stridor: Seen in the ED
Update: ACIP 2024 Adult Immunization Recommendations
This summary of updates to the ACIP 2024 Adult Vaccination recommendations includes 4 new vaccines and new formulations for COVID-19 and influenza shots.
FDA Approves First Blood Test for Primary Screening of Colorectal Cancer
The Shield blood test is approved for primary CRC screening in adults 45 years and older at average risk for the disease.
Intervention Cuts Alcohol Use in Youths with Chronic Medical Conditions: Daily Dose
Reducing Screen Use Improves Mental Health in Youth: Daily Dose
Finerenone Phase 3 Data Show Benefit in HFpEF, Promise for New Indication
Finerenone treatment achieved a statistically significant reduction in a composite endpoint of CV death and HF events in a population not limited to CKD in T2D, Bayer announced.
HbA1c Time in Range Shows Strong, Consistent Relationship with Dementia in Older Adults with Diabetes
New study findings suggest that in older adults stable HbA1c within individualized target ranges over time may help reduce risk of Alzheimer disease and other dementias.
Semaglutide Sold Online without Prescription May Put Users at Risk for Fraud, Overdose
Semaglutide bought online without a prescription were unregistered, contaminated, and had levels of product that exceeded labeled amount, according to new data.
FDA Approves First Orally Disintegrating Tablet for Birth Control: Daily Dose
Lecanemab Efficacy Continues at 3 Years of Treatment for Early Alzheimer Disease
The lecanemab Clarity AD open label extension study returned no new safety signals and data reflect the therapy's disease modifying effects on key biomarkers.
Obesity and Type 2 Diabetes: Expert Shares 4 Pillars of Management
Caissa Troutman, MD, discusses how clinicians can tailor management plans to reduce risk of developing T2D in patients with obesity.
Intranasal Flu Vaccine Coadministered with High-Dose Shot in Older Adults Superior Over Shot Alone: Daily Dose
HPV Vaccination Rates, Clinician Recommendations Lag at Public Health Care Facilities
HPV series initiation and completion was lower among adolescents seen at public vs private care settings and so was clinician guidance on vaccination in a new study.
